Core Viewpoint - Viemed Healthcare, Inc. has announced a share repurchase program, allowing the company to buy back up to 1,976,441 common shares, which is approximately 5% of the total shares outstanding as of March 31, 2025, to enhance shareholder value [1][2]. Group 1: Share Repurchase Program - The share repurchase program is effective through June 2026 and allows for purchases through open market transactions, block purchases, or other methods compliant with securities laws [1][3]. - Daily purchases will be limited to 25% of the average daily volume for the four weeks preceding the purchase date, with the price paid being the market price at the time of purchase plus applicable brokerage fees [3][4]. - The company has previously repurchased approximately 2.6 million shares since its public listing, demonstrating a commitment to disciplined capital allocation [4]. Group 2: Financial Position and Strategy - Viemed's CEO highlighted strong first quarter 2025 results and increased guidance, indicating robust underlying business fundamentals [4]. - The company has no net debt and full access to a $55 million credit facility, providing ample liquidity for both the share repurchase program and funding growth initiatives [4]. - The company is also in the process of acquiring Lehan's Medical, expected to close in the third quarter of 2025, further supporting its growth strategy [4]. Group 3: Company Overview - Viemed Healthcare is a provider of in-home clinical care for post-acute respiratory healthcare, offering services such as non-invasive ventilators, sleep therapy, and staffing [5]. - The company focuses on delivering efficient in-home treatment through clinical practitioners who provide therapy, education, and counseling using advanced technology [5].